Page 15 - Material Command News Today

CytoSorbents to Report Q1 2021 Operating and Financial Results News provided by Share this article Share this article MONMOUTH JUNCTION, N.J., April 27, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q1 2021 financial results after the market close on Tuesday, May 4, 2021 at 4...

Ticagrelor ( STAR-T) randomized, controlled trial.  Based on this conditional approval, study initiation activities, including clinical trial agreement negotiations and institutional review board (IRB) submissions, can now commence, putting the study ahead of the Companys internal schedule.  The Company has already identified and pre-screened many high-quality U.S. clinical centers that have indicated strong interest to participate in the STAR-T trial.  The Company believes conditions for f...

Breast Cancer Patients Who Drink Non-Diet Soda Have Higher Death Risk Breast cancer patients who drink sugar-sweetened soda regularly are at increased risk for death from any cause and from breast cancer in particular, a new study suggests.   By David Hill-Buffalo Compared to women who never or rarely drank non-diet soda, those who reported drinking non-diet soda five or more times per week had a 62% higher likelihood of dying from any cause, and were 85% more likely to die from breast cancer ...

5 CAMP AS SAYLIYAH, Qatar – Army Field Support Battalion-Qatar has come a considerable way since first receiving orders to deactivate back in January 2020. As one of five battalions in the 401st Army Field Support Brigade, AFSBn-Qatar had a critical mission during the years of relative instability in the Middle East. Even though the mission has changed, with complete deactivation of the organization scheduled for May, the stakes remain the same. Preceding what is currently ...

CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference News provided by Share this article MONMOUTH JUNCTION, N.J., March 12, 2021 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces its participation the Oppenheimer 31 st Annual Healthcare Conference. Chief Executi...

 E-Mail IMAGE: Study first author Nadia Koyratty is an epidemiology PhD candidate in the University at Buffalo School of Public Health and Health Professions. view more  Credit: University at Buffalo BUFFALO, N.Y. -- New research from the University at Buffalo suggests that breast cancer patients who drink sugar-sweetened beverages regularly are at increased risk for death from any cause and breast cancer in particular. Compared to women who never or rarely drank non-diet soda, those...

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb® Media Links Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, GERMANY and MONMOUTH JUNCTION, N.J., March 2, 2021 – B. Braun Avitum AG, a leading manufacturer of medical devices a...

CET- Comunicado - ";ultimaHoraHtml += " " + json.lead + "";}ultimaHoraHtml += ""; document.getElementById("urgente").innerHTML = ultimaHoraHtml; } } }); The CytoSorb adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream./ - CYTOSORBENTS B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI* Continuous Blood Purification Platform wit...

CytoSorbents to Present at the Cowen 41st Annual Health Care Conference News provided by Share this article MONMOUTH JUNCTION, N.J., Feb. 24, 2021 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces its participation the Cowen 41 st Annual Health Care Conference. Chief Executive Officer,...

/PRNewswire/ -- Medcura, Inc., a commercial-stage medical device company, announced today that it has been awarded a $2M follow-on grant to expand its...